FERMT2 (Fermitin Family Member 2), also known as Kindlin-2 or MITD2 (Mitogen-Induced Domain-2), encodes a member of the fermitin family of proteins. Kindlin-2 is a critical integrin-activating protein that plays essential roles in cell adhesion, focal adhesion formation, actin cytoskeleton organization, and cell migration. Genome-wide association studies (GWAS) have identified FERMT2 as a risk gene for late-onset Alzheimer's disease (LOAD), making it a protein of significant interest in neurodegeneration research[1].
| Property | Value |
|---|---|
| Gene Symbol | FERMT2 |
| Full Name | Fermitin Family Member 2 |
| Protein Name | Kindlin-2 (MITD2) |
| Chromosomal Location | 14q22.1 |
| NCBI Gene ID | 10979 |
| Ensembl ID | ENSG00000173702 |
| UniProt ID | Q9BUF5 |
| OMIM ID | 614365 |
Kindlin-2 is a ~80 kDa protein containing several key domains:
| Domain | Location | Function |
|---|---|---|
| F0 domain | N-terminus | Membrane association |
| F1 domain | Central | Integrin binding |
| F2 domain | Central | Phosphatidylinositol phosphate binding |
| F3 domain | C-terminus | Integrin binding, focal adhesion targeting |
| PH domain | C-terminus | Pleckstrin homology (membrane targeting) |
Kindlin-2 is a key activator of integrin receptors through "inside-out" signaling:
Kindlin-2 and talin form a functional complex that fully activates integrins—neither alone is sufficient for maximal activation[2].
Kindlin-2 is primarily localized to:
Kindlin-2 is essential for:
Through interactions with various partners:
Kindlin-2 regulates:
FERMT2 has emerged as a significant AD risk gene through GWAS[4]:
GWAS Evidence:
Potential Mechanisms:
Amyloid-β Metabolism:
Tau Pathology:
Neuroinflammation:
Blood-Brain Barrier:
Evidence from Human Studies:
While not a primary GWAS hit, FERMT2 may play roles:
FERMT2 is overexpressed in several cancers:
This complicates therapeutic targeting.
| Approach | Rationale | Status |
|---|---|---|
| Integrin modulators | Modulate integrin-kindlin interaction | Preclinical |
| Microglial targeting | Enhance Aβ clearance | Research |
| BBB protection | Maintain endothelial function | Research |
| Anti-inflammatory | Reduce neuroinflammation | Investigational |
FERMT2 is expressed in multiple brain regions:
| Region | Expression Level | Cell Types |
|---|---|---|
| Cerebral cortex | High | Pyramidal neurons, astrocytes |
| Hippocampus | High | CA1-CA3 neurons, dentate gyrus |
| Cerebellum | Moderate | Purkinje cells |
| Basal ganglia | Moderate | Medium spiny neurons |
| Substantia nigra | Moderate | Dopaminergic neurons |
| Cell Type | Expression | Function |
|---|---|---|
| Neurons | High | Synaptic plasticity, adhesion |
| Astrocytes | High | BBB support, metabolism |
| Microglia | Moderate | Phagocytosis, inflammation |
| Endothelial cells | Moderate | BBB integrity |
| Oligodendrocytes | Low | Myelin maintenance |
| Protein | Interaction Type | Pathway |
|---|---|---|
| Integrins (β1, β3, β5) | Direct binding | Cell adhesion |
| Talin | Cooperative binding | Integrin activation |
| Vinculin | Focal adhesion | Actin linkage |
| Paxillin | Focal adhesion | Signaling scaffold |
| FAK | Signaling | Adhesion signaling |
| ILK | Signaling complex | Integrin signaling |
Lambert JC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013. ↩︎
Ushio A, et al. Kindlin-2: a key regulator of integrin function. J Cell Sci. 2017. ↩︎
Yu H, et al. Kindlin-2 in cell adhesion and migration. Cell Adh Migr. 2015. ↩︎
Kelley AR, et al. FERMT2 (Kindlin-2) in Alzheimer's disease: genetic and functional studies. Acta Neuropathol. 2018. ↩︎
Liu J, et al. Kindlin-2 and tau pathology in Alzheimer's disease. Acta Neuropathol Commun. 2019. ↩︎
Xie L, et al. Kindlin-2 regulates amyloid-beta clearance and neuroinflammation. Glia. 2018. ↩︎